Patients with rheumatoid arthritis are at increased risk of having cardiovascular deaths. The
investigator's study is aimed at looking at the effects of proven cholesterol lowering
treatment drug called rosuvastatin in rheumatoid arthritis patients on few cardiovascular
markers. Endothelial behaviour improved on treatment.